Home » Markets » AstraZeneca coronavirus vaccine pause 'not necessarily' a setback: UK health minister
AstraZeneca coronavirus vaccine pause 'not necessarily' a setback: UK health minister
AstraZeneca vaccine trial pause is ‘routine’: Dr. Scott Atlas
Adviser to President Trump Dr. Scott Atlas on the AstraZeneca COVID-19 trial being put on pause because of an adverse reaction.
U.K. health Secretary Matt Hancock said Wednesday that AstraZeneca's decision to pause its global trials of a COVID-19 vaccine for safety concerns was "not necessarily" a setback for the drugmaker.
Continue Reading Below
On Tuesday, AstraZeneca PLC, which has been developing a vaccine with Oxford University, temporarily put its late-stage study on hold while it investigates whether a recipient’s “potentially unexplained” illness is a side effect of the vaccine.
ASTRAZENECA'S COVID-19 VACCINE TRIAL IS PUT ON HOLD, STOCK TANKS
Hancock told Sky News on Wednesday that the temporary pause is "obviously a challenge to this particular vaccine trial," but it is not the first time this has happened.